New Technology Indices TA-Technology Index and TA BlueTech-50 Index (temporary name to replace the Tel-Tech Index)

Press Release
17/02/2011
 

The Tel Aviv Stock Exchange’s (TASE) Board of Directors approved upgrade of its technology sector indices, within the framework of developing TASE as a financial hub for technology companies. After launching The TA-Biomed index last year, TASE enhanced its Tel-Tech index to incorporate biomed companies and launched a new TA-Technology index which focuses on TASE-listed electronics, communications, IT and cleantech companies. The changes are scheduled to debut on 3.4.2011.

TA BlueTech-50 (temporary name) 
  • The TA BlueTech-50 Index will include the 50 most highly capitalized companies among those included in the TA-Technology and TA-Biomed indices and will replace the current Tel-Tech Index.
  • The index will include IT, electronics and cleantech companies not currently included in the Tel-Tech index.
  • The base index on the debut date will be identical to the closing price of the Tel-Tech Index on 31.3.2011.
TA-Technology Index 
  • This new index is a composite sectoral index incorporating all shares included on the TASE technology list – which is composed of electronics, communications and IT companies, cleantech companies (dealing with water treatment, alternative energy and waste disposal technologies) and investment firms specializing in hi-tech investments.
  • The TA-Technology index will not include “biomed” shares, as these are included in the TA-Biomed Index.
  • The number of companies in the TA-Technology Index is not limited. The index will comprise all companies meeting threshold requirements for inclusion in the TASE Index Universe.
  • The base index price on the launch date will be identical to the closing Tel-Tech index on 31.3.2011.
Highlights of the new indices (as of 1.2.2011) are summarized below: 

TA-Technology

TA BlueTech-50

 

US $12.5 billion

US $15.8 billion

Market Cap

US $8.3 billion

US $10 billion

Free Float

43

50

No. Shares

10%

10%

Weight Cap

 

“The expansion of publically traded hi-tech and biotechnology enterprises in Israel underscores TASE’s leadership in this area.  TASE’s new tech indices can serve as the underlying asset for various products, such as ETFs and ETNs, which will provide investors a convenient channel of investment in Israel’s innovative high-tech industries”, remarked Ester Levanon, TASE CEO.